Cefflo S 1000mg/500mg Injection
Marketer
Flora Biotech
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefflo S 1000mg/500mg Injection
Ceflo S Injection (1000mg/500mg) combines two medications to combat diverse bacterial infections. Its action inhibits microbial proliferation, thereby controlling infection spread. Administration should always be under a doctor's guidance; strict adherence to the prescribed dosage schedule is crucial. Complete the full treatment course, even with symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and digestive upset are possible side effects; worsenings require immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, breathing difficulty). Disclose all current medications to your physician before use, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While typically non-impairing to driving, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medicine's impact.
Primary Ingredients of Cefflo S 1000mg/500mg Injection
No information provided. Please provide the text you wish me to rewrite.
Uses of Cefflo S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefflo S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Cefflo S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefflo S 1000mg/500mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Cefflo S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefflo S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Cefflo S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefflo S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Cefflo S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Cefflo S 1000mg/500mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cefflo S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication, Cefflo S 1000mg/500mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Cefflo S 1000mg/500mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefflo S 1000mg/500mg Injection :
Omit a Cefflo S 1000mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefflo S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently